BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 1999
View Archived Issues
Cognitive effects of three new antiepileptic drugs examined
Read More
New beta blocker facilitates beating-heart surgery
Read More
Epitope receives CE Mark for OraSure, federal supply authorization in U.S.
Read More
GPC and MorphoSys collaborate on human therapeutic antibody program
Read More
Cortex's schizophrenia drug enhances cognitive function
Read More
Pharmadigm updates DHEA product development
Read More
Company Profile: Phytopharm
Read More
Immunotherapeutic method of treating viral respiratory disease available from NIH
Read More
CXCR receptor antagonists in development at SB for chemokine-mediated disorders
Read More
Malonic acid-based MMP inhibitors with novel binding properties developed at Roche
Read More
SmithKline Beecham synthesizes pharmaceutically active integrin receptor antagonists
Read More
Merck & Co. discovers new series with antithrombin effects
Read More
Potent and selective COX-2 inhibitors described in recent patent literature by Novartis
Read More
University of Michigan team establishes role of IL-17 in pathogenesis of acute lung injury
Read More
Moxonidine metabolite synthesized by Lilly and assessed in SHR
Read More
IDEC-131, an inhibitor of B-cell activation for the treatment of autoimmune disorders
Read More
Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo
Read More
Avandia approved in Mexico, approval recommended in U.S.
Read More
Pruritus: a potential new application for kappa-opioid agonists
Read More
New EAA antagonist from Lilly effective in animal model of TBI
Read More
Antisense oligonucleotide against alpha4 integrin improves paralysis in animal model of MS
Read More
DuPont presents somatostatin analogues YH-137 and YH-138 with antiangiogenic effects
Read More
News from FASEB: novel activators of CFTR currents developed at European universities
Read More
HP-228 reduces obesity and insulin resistance in animal models
Read More
Abbott obtains marketing rights to Meiji cephalosporin in several major markets
Read More
Subject of Alkermes-Janssen collaboration revealed; compound advancing to phase III trials
Read More
Metabolism and disposition of novel anti-HIV agent studied in isolated rat liver
Read More